搜尋結果
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 6 小時前Novo Nordisk's blockbuster weight loss drug, which contains the second generation ... ...
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Forbes· 14 小時前Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US - English News ...
metroradio.com.hk· 21 小時前targets a variant that was dominant earlier this year, the company said. Novavax's ...
FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
CNBC· 18 小時前Novo is aiming to be the first to hit the market with ...
'Pregnancy discrimination across corporate America is still rampant,' author says
CNBC· 6 小時前In the book, "Women Money Power," financial journalist Josie Cox tells the story of ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 23 小時前, opens new tab will only be able to offer a COVID-19 vaccine in the United States ...